>
>
Buccal Drug Delivery Systems Market - By Product (Tablet, Film, Spray, Gel, Patch), Application (Pain Management, Hormone Replacement, Cardiovascular, Respiratory & Neurological Disorder), System (Matrix, Reservoir), End-use – Global Forecast 2024 – 2032
Download Free PDF

Buccal Drug Delivery Systems Market
Get a free sample of this reportGet a free sample of this report Buccal Drug Delivery Systems Market
Is your requirement urgent? Please give us your business email for a speedy delivery!
Buy Now
$4,123 $4,850
15% off
$4,840 $6,050
20% off
$5,845 $8,350
30% off
Buy now
Premium Report Details
Base Year: 2023
Companies covered: 15
Tables & Figures: 358
Countries covered: 23
Pages: 260
Download Free PDF
Buccal Drug Delivery Systems Market Size
Buccal Drug Delivery Systems Market size was valued at around USD 3.9 billion in 2023 and is estimated to grow at 8.6% CAGR from 2024 to 2032. Buccal drug delivery systems involve administering a drug through the buccal mucosa (the lining of the cheek) to achieve systemic or local effects. This method utilizes the mucous membrane inside the mouth to absorb the drug directly into the bloodstream, bypassing the gastrointestinal tract and first-pass metabolism in the liver.
The market is gaining traction due to its ability to enhance drug bioavailability, improve patient compliance, and accommodate ongoing advancements in pharmaceutical drug delivery technologies. The rising prevalence of chronic diseases and a supportive regulatory landscape further bolster its market growth. A key driver for buccal drug delivery systems is the enhanced bioavailability achieved through this route. Buccal administration increases drug bioavailability by bypassing the gastrointestinal tract and hepatic first-pass metabolism, allowing more drug to enter systemic circulation. Additionally, it is non-invasive and easy to administer, improving compliance among those who have difficulty swallowing pills, such as pediatric and geriatric patients.
Moreover, the increasing incidence of chronic diseases, such as cardiovascular diseases and diabetes, which require long-term medication, is also driving the demand for alternative drug delivery systems like buccal routes that offer sustained and controlled drug release.
Buccal Drug Delivery Systems Market Trends
Buccal Drug Delivery Systems Market Analysis
Based on product type, the market is segmented into buccal tablets, buccal films, buccal gels, buccal sprays, and buccal patches. The buccal films segment dominated the market with the largest revenue of USD 1.6 billion in 2023.
Based on application, the buccal drug delivery systems market is segmented into pain management, hormone replacement, cardiovascular diseases, neurological disorders, respiratory disorders, addiction treatment, and mental health disorders. The pain management segment dominated the market and was valued at USD 1.4 billion in 2023.
Based on system type, the buccal drug delivery systems market is bifurcated into matrix systems and reservoir systems. The matrix systems segment held the largest revenue of USD 2.5 billion in 2023.
Based on end-use, the buccal drug delivery systems market is segmented into hospitals, homecare settings, specialty clinics, ambulatory surgery centers, and other end-users. The hospitals segment held the largest revenue of USD 1.7 billion in 2023.
The North America buccal drug delivery systems market is forecasted to reach USD 3.2 billion by 2032, propelled by technological advancements, heightened public awareness, and the rising prevalence of chronic diseases. The U.S. dominated the North America market with the largest revenue of USD 1.4 billion in 2023.
The buccal drug delivery systems market in UK is expected to experience significant and promising growth from 2024 to 2032.
Japan buccal drug delivery systems market is anticipated to witness lucrative growth between 2024 – 2032.
The buccal drug delivery systems market in Saudi Arabia is expected to experience significant and promising growth from 2024 to 2032.
Buccal Drug Delivery Systems Market Share
The buccal drug delivery systems sector is competitive in nature, with a mix of major global and smaller to medium-sized companies competing for market share. A pivotal aspect of market strategy involves the continual introduction of innovations such as advanced mucoadhesive buccal systems, buccal films and tablets with advanced formulations, nano-enhanced buccal delivery systems, and bio-responsive buccal drug delivery systems. Notably, prominent industry players command considerable influence in this dynamic landscape, often driving forward advancements through substantial investments in research and development. Additionally, strategic alliances, acquisitions, and mergers are instrumental in fortifying market positions and expanding global footprint amidst evolving regulatory landscapes.
Buccal Drug Delivery Systems Market Companies
Some of the eminent market participants operating in the buccal drug delivery systems industry include:
Buccal Drug Delivery Systems Industry News:
The buccal drug delivery systems market research report includes an in-depth coverage of the industry with estimates & forecast in terms of revenue in USD Million from 2021 – 2032 for the following segments:
Click here to Buy Section of this Report
Market, By Product Type
Market, By Application
Market, By System Type
Market, By End-use
The above information is provided for the following regions and countries: